Kondo Chisa相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Association Between Laboratory Values and Covert Hepatic Encephalopathy in Patients with Liver Cirrhosis: A Multicenter, Retrospective Study

肝硬化患者实验室指标与隐匿性肝性脑病的相关性：一项多中心回顾性研究

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm14061858

Koyano, Kaori; Atsukawa, Masanori; Tsubota, Akihito; Kondo, Chisa; Miwa, Takao; Namisaki, Tadashi; Hiraoka, Atsushi; Toyoda, Hidenori; Tada, Toshifumi; Kobayashi, Yuji; Kawata, Kazuhito; Matsuura, Kentaro; Mikami, Shigeru; Kawabe, Naoto; Oikawa, Tsunekazu; Suzuki, Kenta; Kawano, Tadamichi; Okubo, Tomomi; Arai, Taeang; Tani, Joji; Morishita, Asahiro; Iwasa, Motoh; Ishikawa, Toru; Ikegami, Tadashi; Tanaka, Yasuhito; Shimizu, Masahito; Yoshiji, Hitoshi; Iwakiri, Katsuhiko

发表日期：2025

文献求助收藏

Low vitamin D levels accelerates muscle mass loss in patients with chronic liver disease

维生素D水平过低会加速慢性肝病患者的肌肉量流失。

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0299313

Okubo, Tomomi; Atsukawa, Masanori; Tsubota, Akihito; Ono, Hiroki; Kawano, Tadamichi; Yoshida, Yuji; Arai, Taeang; Hayama, Korenobou; Itokawa, Norio; Kondo, Chisa; Iwakiri, Katsuhiko

发表日期：2024

文献求助收藏

Impact of pemafibrate in patients with metabolic dysfunction-associated steatotic liver disease complicated by dyslipidemia: A single-arm prospective study

培马贝特对伴有血脂异常的代谢功能障碍相关脂肪肝患者的影响：一项单臂前瞻性研究

期刊:JGH Open

影响因子:1.5

doi:10.1002/jgh3.13057

Ono, Hiroki; Atsukawa, Masanori; Tsubota, Akihito; Arai, Taeang; Suzuki, Kenta; Higashi, Tetsuyuki; Kitamura, Michika; Shioda-Koyano, Kaori; Kawano, Tadamichi; Yoshida, Yuji; Okubo, Tomomi; Hayama, Korenobu; Itokawa, Norio; Kondo, Chisa; Nagao, Mototsugu; Iwabu, Masato; Iwakiri, Katsuhiko

发表日期：2024

文献求助收藏

A novel formula used for predicting hepatocellular carcinoma after the achievement of sustained virologic response by direct-acting antivirals in patients with chronic hepatitis C

一种用于预测慢性丙型肝炎患者在接受直接抗病毒药物治疗并获得持续病毒学应答后发生肝细胞癌的新公式

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0292019

Yoshida, Yuji; Atsukawa, Masanori; Kondo, Chisa; Kitamura, Michika; Shioda-Koyano, Kaori; Kawano, Tadamichi; Ono, Hiroki; Hayama, Korenobu; Okubo, Tomomi; Arai, Taeang; Itokawa, Norio; Iwakiri, Katsuhiko

细胞生物学

发表日期：2023

文献求助收藏

How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis

2022 年欧洲心脏病学会/欧洲呼吸学会指南如何修改门静脉高压合并肝硬化患者的门肺高压诊断？一项事后分析

期刊:JGH Open

影响因子:1.5

doi:10.1002/jgh3.12949

Atsukawa, Masanori; Tsubota, Akihito; Tamura, Yuichi; Koyano-Shioda, Kaori; Kawano, Tadamichi; Okubo, Tomomi; Hayama, Korenobu; Arai, Taeang; Itokawa, Norio; Taniguchi, Yu; Tamura, Yudai; Kondo, Chisa; Iwakiri, Katsuhiko

肺动脉高压

发表日期：2023

文献求助收藏

Antifibrotic effect and long-term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus

SGLT2抑制剂对合并糖尿病的非酒精性脂肪性肝病患者的抗纤维化作用及长期疗效

期刊:Hepatology Communications

影响因子:4.6

doi:10.1002/hep4.2069

Arai, Taeang; Atsukawa, Masanori; Tsubota, Akihito; Mikami, Shigeru; Haruki, Uojima; Yoshikata, Keiichiro; Ono, Hiroki; Kawano, Tadamichi; Yoshida, Yuji; Tanabe, Tomohide; Okubo, Tomomi; Hayama, Korenobu; Nakagawa-Iwashita, Ai; Itokawa, Norio; Kondo, Chisa; Kaneko, Keiko; Nagao, Mototsugu; Inagaki, Kyoko; Fukuda, Izumi; Sugihara, Hitoshi; Iwakiri, Katsuhiko

发表日期：2022

文献求助收藏

Efficacy and safety of oral semaglutide in patients with non-alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study

口服索玛鲁肽治疗合并2型糖尿病的非酒精性脂肪性肝病患者的疗效和安全性：一项初步研究

期刊:JGH Open

影响因子:1.5

doi:10.1002/jgh3.12780

Arai, Taeang; Atsukawa, Masanori; Tsubota, Akihito; Ono, Hirotaka; Kawano, Tadamichi; Yoshida, Yuji; Okubo, Tomomi; Hayama, Korenobu; Nakagawa-Iwashita, Ai; Itokawa, Norio; Kondo, Chisa; Nagao, Mototsugu; Iwakiri, Katsuhiko

发表日期：2022

文献求助收藏

Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data

钠-葡萄糖协同转运蛋白2抑制剂对非酒精性脂肪性肝病合并2型糖尿病患者的影响：基于真实世界数据的倾向评分匹配分析

期刊:Therapeutic Advances in Endocrinology and Metabolism

影响因子:4.6

doi:10.1177/20420188211000243

Arai, Taeang; Atsukawa, Masanori; Tsubota, Akihito; Mikami, Shigeru; Ono, Hiroki; Kawano, Tadamichi; Yoshida, Yuji; Tanabe, Tomohide; Okubo, Tomomi; Hayama, Korenobu; Nakagawa-Iwashita, Ai; Itokawa, Norio; Kondo, Chisa; Kaneko, Keiko; Emoto, Naoya; Nagao, Mototsugu; Inagaki, Kyoko; Fukuda, Izumi; Sugihara, Hitoshi; Iwakiri, Katsuhiko

发表日期：2021

文献求助收藏

Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease

肝纤维化与经肝活检证实患有非酒精性脂肪肝疾病的患者的颈动脉粥样硬化相关。

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-021-95581-8

Arai, Taeang; Atsukawa, Masanori; Tsubota, Akihito; Kato, Keizo; Abe, Hiroshi; Ono, Hirotaka; Kawano, Tadamichi; Yoshida, Yuji; Tanabe, Tomohide; Okubo, Tomomi; Hayama, Korenobu; Nakagawa-Iwashita, Ai; Itokawa, Norio; Kondo, Chisa; Kaneko, Keiko; Emoto, Naoya; Nagao, Mototsugu; Inagaki, Kyoko; Fukuda, Izumi; Sugihara, Hitoshi; Iwakiri, Katsuhiko

动脉粥样硬化

发表日期：2021

文献求助收藏

A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C

一种预测慢性丙型肝炎患者肝硬化的新型无创公式

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0257166

Atsukawa, Masanori; Tsubota, Akihito; Kondo, Chisa; Uchida-Kobayashi, Sawako; Takaguchi, Koichi; Tsutsui, Akemi; Nozaki, Akito; Chuma, Makoto; Hidaka, Isao; Ishikawa, Tsuyoshi; Iwasa, Motoh; Tamai, Yasuyuki; Tobari, Maki; Matsuura, Kentaro; Nagura, Yoshihito; Abe, Hiroshi; Kato, Keizo; Suzuki, Kenta; Okubo, Tomomi; Arai, Taeang; Itokawa, Norio; Toyoda, Hidenori; Enomoto, Masaru; Tamori, Akihiro; Tanaka, Yasuhito; Kawada, Norifumi; Takei, Yoshiyuki; Iwakiri, Katsuhiko

发表日期：2021

文献求助收藏